Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients

Immunobiology

Volumn 220, Issue 3, 2015, Pages 414-421

  Kompoti, Maria ^a   Michopoulos, Alexandros ^b   Michalia, Martha ^a   Clouva Molyvdas, Phyllis Maria ^a   Germenis, Anastasios E ^b   Speletas, Matthaios ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

BAFFR; C2 complement; Intensive care unit; Sepsis; TACI; TLR4

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ADAPTIVE IMMUNITY; ADULT; AGED; APACHE; ARTICLE; BACTERIUM ISOLATE; BAFFR GENE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; IMMUNOGENETICS; IMMUNOGLOBULIN DEFICIENCY; INFECTION RISK; INNATE IMMUNITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; RISK ASSESSMENT; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; TACI GENE; TLR4 GENE;

EID: 84964226707     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.10.006     Document Type: Article

References (55)

1. Abraham E. Alterations in cell signaling in sepsis. Clin. Infect. Dis. 2005, 41(Suppl. 7):459-464.
2. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., Lowry S.F. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 2002, 186:1522-1525.
3. Ahmad-Nejad P., Denz C., Zimmer W., Wacker J., Bugert P., Weiss C., Quintel M., Neumaier M. The presence of functionally relevant toll-like receptor polymorphisms does not significantly correlate with development or outcome of sepsis. Genet. Test. Mol. Biomarkers 2011, 15:645-651.
4. Ameziane N., Beillat T., Verpillat P., Chollet-Martin S., Aumont M.C., Seknadji P., Lamotte M., Lebret D., Ollivier V., de Prost D. Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler. Thromb. Vasc. Biol. 2003, 23:61-64.
5. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
6. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Personal. Soc. Psychol. 1986, 51:1173-1182.
7. Barroeta Seijas A.B., Graziani S., Cancrini C., Finocchi A., Ferrari S., Miniero R., Conti F., Zuntini R., Chini L., Chiarello P., et al. The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood. Int. J. Immunopathol. Pharmacol. 2012, 25:407-414.
8. Boekholdt S.M., Agema W.R., Peters R.J., Zwinderman A.H., van der Wall E.E., Reitsma P.H., Kastelein J.J., Jukema J.W. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 2003, 107:2416-2421.
9. Boomer J.S., Green J.M., Hotchkiss R.S. The changing immune system in sepsis. Is individualized immune-modulatory therapy the answer?. Virulence 2005, 5:1-12.
10. Carregaro F., Carta A., Cordeiro J.A., Lobo S.M., Silva E.H., Leopoldino A.M. Polymorphisms IL10-819 and TLR-2 are potentially associated with sepsis in Brazilian patients. Mem. Inst. Oswaldo Cruz 2010, 105:649-656.
11. Carson I.V.,W.F, Kunkel S. Immune cell dysfunction as a consequence of severe sepsis. Severe Sepsis and Septic Shock, Understanding a Serious Killer 2012, Intech. 10.5772/28009. R. Fernandez (Ed.).
12. Charlson M.E., Pompei P., Ales K.L., MacKenzie R.C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 1987, 40:373-383.
13. Ferwerda B., McCall M.B., Alonso S., Giamarellos-Bourboulis E.J., Mouktaroudi M., Izagirre N., Syafruddin D., Kibiki G., Cristea T., Hijmans A., et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16645-16650.
14. Ferwerda B., McCall M.B., Verheijen K., Kullberg B.J., van der Ven A.J., van der Meer J.W., Netea M.G. Functional consequences of toll-like receptor 4 polymorphisms. Mol. Med. 2008, 14:346-352.
15. Feterowski C., Emmanuilidis K., Miethke T., Gerauer K., Rump M., Ulm K., Holzmann B., Weighardt H. Effects of functional toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 2003, 109:426-431.
16. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 1991, 4:359-395.
17. Gao H., Leaver S.K., Burke-Gaffney A., Finney S.I. Severe sepsis and toll-like receptors. Semin. Immunopathol. 2008, 30:29-40.
18. Hawn T.R., Scholes D., Li S.S., Wang H., Yang Y., Roberts P.L., Stapleton A.E., Janer M., Aderem A., Stamm W.E., Zhao L.P., Hooton T.M. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS ONE 2009, 4:e5990.
19. Henckaerts L., Nielsen K.R., Steffensen R., Van Steen K., Mathieu C., Giulietti A., Wouters P.J., Milants I., Vanhorebeek I., Langouche L., Vermeire S., Rutgeerts P., Thiel S., Wilmer A., Hansen T.K., Van den Berghe G. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit. Care Med. 2009, 37:192-201. e1-e3.
20. Hildebrand J.M., Luo Z., Manske M.K., Price-Troska T., Ziesmer S.C., Lin W., Hostager B.S., Slager S.L., Witzig T.E., Ansell S.M., et al. A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling. J. Exp. Med. 2010, 207:2569-2579.
21. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162:3749-3752.
22. Johnson C.A., Densen P., Hurford R.K., Colten H.R., Wetsel R.A. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J. Biol. Chem. 1992, 267:9347-9353.
23. Ikushima H., Nishida T., Takeda K., Ito T., Yasuda T., Yano M., Akira S., Matsuda H. Expression of toll-like receptors 2 and 4 is downregulated after operation. Surgery 2004, 135:376-385.
24. Kanswal S., Katselneson N., Selvapandiyan A., Bram R.J., Akkoyunlu M. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL. J. Immunol. 2008, 181:976-990.
25. Kawasaki T., Ogata M., Kawasaki C., Tomihisa T., Okamoto K., Shigematsu A. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth. Analg. 2001, 92:1322-1326.
26. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., Willeit J., Schwartz D.A. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 2002, 347:185-192.
27. Kumpf O., Giamarellos-Bourboulis E.J., Koch A., Hamann L., Mouktaroudi M., Oh D.Y., Latz E., Lorenz E., Schwartz D.A., Ferwerda B., Routsi C., Skalioti C., Kullberg B.J., van der Meer J.W., Schlag P.M., Netea M.G., Zacharowski K., Schumann R.R. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit. Care 2010, 14:R103.
28. Liadaki K., Petinaki E., Skoulakis C., Tsirevelou P., Klapsa D., Germenis A.E., Speletas M. Toll-like receptor 4 gene (TLR4), but not TLR2, polymorphisms modify the risk of tonsillar disease due to Streptococcus pyogenes and Haemophilus influenzae. Clin. Vaccine Immunol. 2011, 18:217-222.
29. Lin M.T., Albertson T.E. Genomic polymorphisms in sepsis. Crit. Care Med. 2004, 32:569-579.
30. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med 2002, 162:1028-1032.
31. Losi C.G., Silini A., Fiorini C., Soresina A., Meini A., Ferrari S., Notarangelo L.D., Lougaris V., Plebani A. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J. Clin. Immunol. 2005, 25:496-502.
32. Mackay F., Schneider P., Rennert P., Browning J.L. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 2003, 21:231-264.
33. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003, 348:1546-1554.
34. Miller S.I., Ernst R.K., Bader M.W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005, 3:36-46.
35. Nachtigall I., Tamarkin A., Tafelski S., Weimann A., Rothbart A., Heim S., Wernecke K.D., Spies C. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. J. Int. Med. Res. 2014, 42:93-110.
36. Nakada T.A., Hirasawa H., Oda S., Shiga H., Matsuda K., Nakamura M., Watanabe E., Abe R., Hatano M., Tokuhisa T. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J. Surg. Res. 2005, 129:322-328.
37. Opal S.M., Esmon C.T. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit. Care 2003, 7:23-38.
38. Pieper K., Grimbacher B., Eibel H. B-cell biology and development. J. Allergy Clin. Immunol. 2013, 131:959-971.
39. Pieper K., Rizzi M., Speletas M., Smulski C.R., Sic H., Kraus H., Salzer U., Fiala G.J., Schamel W.W., Lougaris V., et al. A common single nucleotide polymorphism impairs B-cell activating factor receptor's multimerization, contributing to common variable immunodeficiency. J. Allergy Clin. Immunol. 2014, 133:1222-1225.
40. Pongrantz G., Hochrinner H., Straub R.H., Lang S., Brünnler T. B-cell activating factor of the tumor necrosis factor family (BAFF) behaves as an acute phase reactant in acute pancreatitis. PLOS ONE 2013, 8:54297.
41. Roderburg C., Koch A., Tacke F., Nieuwenhuijsen L., Bruensing J., Vargas Cardenas D., Kreggenwinkel K., Vucur M., Koppe C., Jungebluth P., et al. Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients. J. Crit. Care 2013, 28. 882.e1-882.e11.
42. Sáenz-Cuesta M., Martínez-Pomar N., de Gracia J., Echaniz P., Villegas E., Prada A., Otaegui D., Matamoros N., Cuadrado E. TACI mutation in Good's Syndrome: in search of a genetic basis. Clin. Immunol. 2012, 145:27-30.
43. Salzer U., Bacchelli C., Buckridge S., Pan-Hammarstrom Q., Jennings S., Lougaris V., Bergbreiter A., Hagena T., Birmelin J., Plebani A., et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009, 113:1967-1976.
44. Shalhub S., Junker C.E., Imahara S.D., Mindrinos M.N., Dissanaike S., O'Keefe G.E. Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study. J. Trauma 2009, 66:115-122.
45. Song Z., Yin J., Yao C., Sun Z., Shao M., Zhang Y., Tao Z., Huang P., Tong C. Variants in the Toll-interacting protein gene are associated with susceptibility to sepsis in the Chinese Han population. Crit. Care 2011, 15:R12.
46. Speletas M., Merentiti V., Kostikas K., Liadaki K., Minas M., Gourgoulianis K., Germenis A.E. Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers. Clin. Dev. Immunol. 2009, 2009:260286.
47. Speletas M., Mamara A., Papadopoulou-Alataki E., Iordanakis G., Liadaki K., Bardaka F., Kanariou M., Germenis A.E. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies. J. Clin. Immunol. 2011, 31:550-559.
48. Speletas M., Salzer U., Florou Z., Petinaki E., Daniil Z., Bardaka F., Gourgoulianis K.I., Skoulakis C., Germenis A.E. Heterozygous alterations of TNFRSF13B/TACI in tonsillar hypertrophy and sarcoidosis. Clin. Dev. Immunol. 2013, 2013:532437.
49. Stüber F. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy?. J. Am. Soc. Nephrol. 2001, 12(Suppl. 1):60-64.
50. Tabrizi A.R., Zehnbauer B.A., Freeman B.D., Buchman T.G. Genetic markers in sepsis. J. Am. Coll. Surg. 2001, 192:106-117.
51. Tang B.M., Huang S.J., Mclean A.S. Genome-wide transcription profiling of human sepsis: a systemic review. Crit. Care 2010, 14:R237.
52. Van der Graaf C.A., Netea M.G., Morré S.A., Den Heijer M., Verweij P.E., Van der Meer J.W., Kullberg B.J. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine Netw. 2006, 17:29-34.
53. Villar J., Maca-Meyer N., Perez-Mendez L., Flores C. Bench-to-bedside review: understanding genetic predisposition to sepsis. Crit. Care 2004, 8:180-189.
54. Yuan F.F., Marks K., Wong M., Watson S., de Leon E., McIntyre P.B., Sullivan J.S. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol. Cell Biol. 2008, 86:268-270.
55. Zhu L., Li X., Miao C. Lack of association between TLR4 Asp299Gly and Thr399Ile polymorphisms and sepsis susceptibility: a meta-analysis. Gene 2012, 501:213-218.